Paying Off Generics To Prevent Competition With Brand Name Drugs: Should It Be Prohibited?: Hearing Before The Committee On The Judiciary, United Stat
Author(s)
United States Congress. Senate. Committee On The Judiciary.
United States Congress. Senate. Committee On The Judiciary.
I Didn't Say Orphan Often: The Benefits Of A Bright-line Rule Barring Brand To Generic Payments In Hatch-waxman Patent Settlements. Distributed To Some Depository Libraries In Microfiche. Shipping List No.: 2007-0225-p. Serial No. J-110-4. Includes Bibliographical References. Also Available Via Internet From The Gpo Access Web Site. Address As Of 4/12/07: Http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=110%5fsenate%5fhearings? Current Access Is Available Via Purl.
| Name in long format: | Paying Off Generics To Prevent Competition With Brand Name Drugs: Should It Be Prohibited?: Hearing Before The Committee On The Judiciary, United Stat |
|---|---|
| ISBN-10: | 0160783526 |
| ISBN-13: | 9780160783524 |
| Book language: | en |
| Binding: | Hardcover |
| Publisher: | Not Avail |
